Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds

Carcinogenesis. 1992 Jun;13(6):1019-23. doi: 10.1093/carcin/13.6.1019.


The inhibitory effect of 40 and 80% maximum tolerated dose (MTD) levels of piroxicam, ibuprofen, ketoprofen and glycyrrhetinic acid on colon carcinogenesis was investigated in male F344 rats. The MTD levels of piroxicam, ibuprofen, ketoprofen and glycyrrhetinic acid as determined in male F344 rats were 500, 500, 250 and 3000 p.p.m. respectively. At 5 weeks of age, groups of male F344 rats were fed the control (AIN-76A) diet and 40 and 80% MTD levels of each test agent in AIN-76A diet. At 7 weeks of age, all animals except the vehicle (saline)-treated controls received azoxymethane (AOM) at a dose rate of 15 mg/kg body wt, once weekly for 2 weeks. All animals were necropsied 50 weeks after the second AOM injection and colon tumor incidences were compared among the groups fed the control diet and chemopreventive agents. Animals fed 400 (80% MTD) and 200 p.p.m. (40% MTD) of piroxicam, 400 p.p.m. (80% MTD) of ibuprofen and 200 p.p.m. (80% MTD) of ketoprofen showed a significant inhibition of colon tumorigenesis as compared to those fed the control diet. Results analyzed by the linear regression method suggested a dose-dependent inhibition of colon carcinogenesis with increasing levels of piroxicam or ibuprofen. In contrast, glycyrrhetinic acid had no measurable chemopreventive effect on colon carcinogenesis.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Azoxymethane
  • Colonic Neoplasms / chemically induced
  • Colonic Neoplasms / prevention & control*
  • Glycyrrhetinic Acid / pharmacology*
  • Ibuprofen / pharmacology*
  • Ketoprofen / pharmacology*
  • Male
  • Piroxicam / pharmacology*
  • Random Allocation
  • Rats
  • Rats, Inbred F344


  • Piroxicam
  • Ketoprofen
  • Azoxymethane
  • Glycyrrhetinic Acid
  • Ibuprofen